Find a Doctor
Solmaz Sahebjam, MD
Director of the Clinical Research UnitLeader of the Phase 1 Clinical Trial Program
Sub Specialty: Medical Oncology
Cancer Focus: Brain Cancer, Glioblastoma, Meningioma
Dr. Sahebjam is a Medical Oncologist/Neuro-Oncologist with research interest in early phase drug development for all cancer types and treatment of primary and metastatic central nervous system tumors. She is an Associate Member at Moffitt Cancer Center and University of South Florida. Dr. Sahebjam is currently Leader of Phase 1 Program and Director of Clinical Research Unit (CRU) at Moffitt Cancer Center. She is principal investigator and co-investigator of a broad range of early phase investigator-initiated and pharmaceutical sponsored therapeutic trials. Dr. Sahebjam is the recipient of prestigious national/international awards such as Cancer Clinical Investigator Team Leadership Award from National Cancer Institute (NCI), American Society of Clinical Oncology (ASCO)/Conquer Cancer Foundation Career Development Award, Canadian Institute of Health Research (CIHR)/Canadian Association of Medical Oncologists (CAMO) Fellowship Award. Dr. Sahebjam holds boards from the following: Medical Oncology from Royal College of Physicians and Surgeons of Canada, Medical Oncology from European Society of Medical Oncology, Medical Oncology from American Board of Internal Medicine, Internal Medicine from American Board of Internal Medicine, and Internal Medicine from Royal College of Physicians and Surgeons of Canada.
Education & Training
Start Year: 2016 End Year: 2017 Junior Faculty Research Awards in Clinical Science, Sponsor: Moffitt Cancer Center
CLINICAL TRIAL 20174
CLINICAL TRIAL 20619
CLINICAL TRIAL 19956
If you believe you are eligible for one of these trials or studies, please call
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including: